Phastar Scoops Prestigious 2024 Scrip Award

Phastar, a global specialist biometrics contract research organization (CRO), has won the Best CRO - Specialist Providers category at the 2024 Scrip Awards.

Oxford Nanopore and UK Biobank to create world’s first epigenetic dataset targeting the causes of cancer, dementia, complex disease

Oxford Nanopore Technologies announced a new collaboration with UK Biobank to create the world’s first comprehensive, large-scale epigenetic dataset.

Intelliguard and Codonics Partner to Strengthen Patient Safety

Intelliguard, a provider of medication management and data-intelligence solutions, announces a strategic partnership with Codonics, a global leader in healthcare technology offering cutting-edge solutions for patient safety. This partnership allows Intelliguard’s Mira Care Station customers to leverage the Codonics Safe Label System (SLS) for fast, compliant, and standardized syringe labeling, ensuring a closed-loop medication process in operating rooms.

CB Insights Recognizes Proscia Among Most Promising Digital Health Companies Of 2024

Proscia also ranks as the top vendor in diagnostic digital pathology market landscapes.

New digital health fund KELES appoints three expert advisors to accelerate healthcare growth across Europe

KELES, venture capital firm led by digital health investors David Buller and Laurent Van Lerberghe, appoints three expert advisors to strengthen its leadership team and accelerate progress in European digital health innovation.

Abselion raises £6.6 million led by M Ventures to bring disruptive at-line protein analyser, Amperia, to market

Abselion has secured £6.6 million in Series A financing to bring its award-winning Amperia system to market.

Cotiviti Welcomes Seasoned Technology Executive Suvajit Gupta as Chief Technology Officer

Biocair strengthens its customer focus in 2024 and prepares for another year of growth

Duke Street Bio Announces First Patient Dosed in Phase I Trial with DSB2455, a Next Generation PARP1 Selective Inhibitor for the Treatment of Solid Tumours

Duke Street Bio Ltd has announced that the first patient has been dosed with its highly selective PARP1 inhibitor, DSB2455, in a Phase 1 clinical trial after European Medicines Agency approval earlier this year.

Capricor Therapeutics Showcases Groundbreaking Exosome Therapy Platform at 2024 AAEV Annual Meeting

Capricor Therapeutics announced that it would introduce the abstract about the pre-clinical data, giving a spotlight on the therapeutic potential of its StealthX exosome platform technology at the 2024 American Association of Extracellular Vesicles Annual Meeting in Texas.

Clinion Wins 2024 SCDM Innovation Award for Excellence in Clinical Data Science

Clinion’s groundbreaking platform is revolutionizing clinical trials, demonstrating how cutting-edge technology is expediting the journey of new therapies to market.

India Charts BioE3 Policy to Propel Advanced Biomanufacturing

The government announced the BioE3 (Biotechnology for Economy, Environment and Employment) policy, a strategic plan to take India to the next era of industrialization through advanced biomanufacturing. Enhancing India’s biomanufacturing capabilities by integrating science, technology, engineering, and manufacturing will enable institutions, universities, startups, and industries in India to participate in innovation, thereby supporting the growth of the upstream bioprocessing market.

Tillotts Pharma partners with Pioneer for the marketing and distribution of Tillotts` product Asacol® in the People’s Republic of China

Tillotts Pharma AG and Pioneer Pharma (Hong Kong) Co., Limited has announced the signing of an exclusive agreement covering the distribution and marketing of Tillotts’ product Asacol® Tablets 800mg in the mainland of the People’s Republic of China.

Hovione Expands Global Spray Drying Capacity with Significant Investment in the USA and Ireland

AKASA Named Among Fastest Growing Generative AI Startups to Watch

Phreesia Named to The Software Report’s “Top 100 Software Companies” for the Third Consecutive Year

Phreesia has been selected by The Software Report as one of the “Top 100 Software Companies of 2024” for a third consecutive year.

Biopharma PEG Offers 30% Thanksgiving Discount on Monodispersed PEGs

Biopharma PEG Scientific Inc. is offering a 30% Thanksgiving discount on select monodispersed PEGs, including mPEG36-NH2, N3-PEG6-OH, and N3-PEG11-NH2. These high-purity, GMP-grade products are ideal for applications like PEGylation, ADC linkers, and PROTAC linkers. The offer is valid until December 4, 2024, at 23:59 EST. Contact us to take advantage of this limited-time promotion.

Amprion Announces Landmark Study in The Lancet Neurology

Novel synSAA Advances Diagnostic Accuracy for Multiple System Atrophy and Related Disorders

1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

eClinical Solutions Positioned as Highest Leader in Everest Group’s Life Sciences Clinical Data and Analytics (D&A) Platforms PEAK Matrix® Assessment 2024

Industry recognition highlights company’s diverse portfolio mix, flexibility and ease of deployment, and data integration capabilities, driving real-time review and insights